NOT FDA-APPROVED AS A DRUG

NAD+ (Nicotinamide Adenine Dinucleotide)

Not technically a peptide, a small molecule your cells need for energy production. The longevity world's favorite IV drip and the basis of the NMN and NR supplement boom. Worth understanding before deciding what to do about it.

The 30-second read

NAD+ is a coenzyme, a small molecule your cells use in roughly 500 different chemical reactions, most importantly to convert food into energy. NAD+ levels decline with age, which sounds like an obvious problem to fix. The longevity world has tried two approaches: IV NAD+ infusions (delivered at clinics, often expensive, often weekly or monthly) and oral precursors (NMN and NR, sold as supplements). Both raise NAD+ levels in the body. What they actually do for human health and aging, beyond raising the lab marker, is much less clear. Animal data is encouraging. Human trials are early and produce mixed results. The "feels great after IV" reports are real. The "extends healthspan" claims are not yet proven.

Why this is on people's radar

NAD+'s longevity story has been driven by a particular research path. David Sinclair's lab at Harvard published influential work on sirtuins, a family of enzymes that depend on NAD+ to function. Sirtuins regulate aging-related processes, and they only work if NAD+ is available. NAD+ levels decline with age. Connecting the dots: maybe boosting NAD+ keeps sirtuins active and slows some aging processes. That hypothesis powered the entire NMN and NR supplement industry and the IV-NAD+ longevity-clinic trend.

The clinical reality has been more complicated. Animal studies of NAD+ precursors (NMN, NR) have shown encouraging results in mouse models of aging, improved metabolic function, better exercise capacity, modest lifespan extensions in some studies. Human trials have been smaller and mixed. Some show metabolic improvements; others show that NAD+ levels rise but downstream health markers don't change as much as the supplement marketing suggests.

Then there's the IV-NAD+ phenomenon. Longevity clinics, biohacker hubs, and high-end wellness centers offer NAD+ infusions ranging from a few hundred to over a thousand dollars per session. The subjective experience, many people report feeling more energetic and clear-headed after, is real. Whether that's the IV NAD+ doing something specific or a combination of placebo, hydration, and the careful-attention experience of an IV clinic is genuinely unclear.

What people are usually trying to do with it

People exploring NAD+ are usually focused on:

  • Supporting cellular energy production and feeling generally more energetic
  • Slowing some aspects of biological aging
  • Improving metabolic flexibility and insulin sensitivity
  • Recovering faster from physical or mental stress
  • Adding "the longevity infusion" to a comprehensive aging-prevention protocol
  • Supporting recovery from illness, including post-COVID fatigue

What the science actually shows

Plain-English summary of what's been demonstrated and what hasn't:

NAD+ levels decline with age

Well-documented in human and animal studies. Tissue NAD+ levels typically decrease across the adult lifespan. This is the foundational observation behind the longevity hypothesis.1

Oral precursors raise NAD+ levels

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) consistently raise blood NAD+ levels in human trials. The biochemistry works as advertised.2

Animal lifespan and healthspan

Mouse studies of NAD+ precursors have shown improvements in metabolic markers, mitochondrial function, exercise capacity, and modest lifespan extensions. The effects in mice are real and reasonably consistent.3

Human metabolic outcomes, mixed

Human trials of NMN and NR have shown some improvements in metabolic markers (insulin sensitivity, body composition) in some populations and minimal effects in others. The translation from "raises NAD+" to "improves health" is less reliable in humans than in mice.4

IV NAD+, almost no rigorous evidence

The longevity-clinic IV NAD+ trend has very little controlled human evidence. Subjective reports of energy and clarity are common; whether the effect is specifically due to IV NAD+ rather than placebo, hydration, or the careful attention of an IV experience hasn't been rigorously tested.5

What hasn't been demonstrated

That raising NAD+ extends human lifespan or healthspan in any clinically meaningful way. That IV NAD+ specifically produces benefits that oral precursors don't. That high-dose long-term NAD+ supplementation is safe, the dose-response and long-term safety picture isn't well-characterized.

The honest read

What's solid:

NAD+ is essential for cellular energy production, that's textbook biochemistry. NAD+ levels decline with age. Oral precursors (NMN, NR) reliably raise NAD+ levels. Mouse studies are reasonably consistent. There's a real biological mechanism here.

What's still being worked out:

Whether raising NAD+ in humans translates into the longevity and healthspan benefits the marketing implies. The bridge from "biomarker improves" to "you live longer or better" is one of the hardest things to prove in aging biology, and the human data is genuinely mixed. Whether IV NAD+ does anything specific that oral precursors don't isn't established.

What's hyped beyond the evidence:

"Anti-aging IV" framing. Claims that NAD+ infusions reverse biological age or extend lifespan in humans, those claims rest on mouse data and biomarker improvements, not on outcomes data. Subjective reports of feeling better after IV NAD+ are real, but attributing the effect specifically to NAD+ versus placebo and IV-experience effects isn't supported by rigorous trials. The supplement industry around NMN and NR has often run ahead of what the human trials actually show.

Things to know if you're looking into it

  • Three main forms: IV NAD+ infusions (clinic-administered), oral NMN, and oral NR. All raise NAD+ in different ways.
  • IV NAD+ is not a peptide: it's a small-molecule coenzyme. We include it here because of its prominence in the same longevity conversations as peptides like MOTS-c and SS-31.
  • Cost varies wildly: oral NMN and NR supplements run roughly $30 to $80 per month at typical doses. IV NAD+ sessions at longevity clinics typically run $200 to $1,500+ per session.
  • IV side effects can be uncomfortable: fast-rate IV NAD+ can produce flushing, chest tightness, and a "burning" sensation that resolves with slower infusion. Most clinics now use slower protocols.
  • FDA status: NAD+, NMN, and NR are regulated as dietary supplements (oral forms) or as compounded preparations (IV). None is FDA-approved as a drug for any specific indication. The FDA's stance on oral NMN as a supplement has shifted multiple times, worth checking current status.
  • The longevity-clinic experience matters: if part of what's helping is the careful attention, hydration, and rest involved in an IV session, that's real but not specifically NAD+.
  • Specific dosing protocols, mechanism, and the full reference list: all in the "Want to go deeper?" section below.

Reconstitution & dose calculator

NAD+ is a coenzyme, not a peptide. Calculator below covers the subcutaneous research route — IV infusions and oral NMN/NR are different products with different dose math. Not FDA-approved as a drug. NAD+ is dose-sensitive: too much too fast produces real, uncomfortable side effects (chest pressure, anxiety, GI upset, flushing). Going slow during ramp-up is the single most important thing. This is an educational reference, not dosing guidance.
BAC water is fine for shorter-term use; consider 0.6% acetic acid for longer storage at higher concentrations. NAD+ dissolves in BAC water (the defaults below assume that), and BAC's preservative is convenient for multi-dose vials. NAD+ does benefit from acidic pH for stability at higher concentrations and longer storage windows — if you're working with the 1000 mg vial and expect to take more than 30 days to use it, reconstituting with 0.6% acetic acid water instead extends usable life. Slight yellow tint is normal; deep yellow or brown indicates degradation and the vial should be discarded.
Ramp-up start
50 mg/day
Week 1 of 2–4 week ramp
Maintenance
100–200 mg/dose
Daily, or 2–3× weekly after ramp
Max SubQ
250 mg/dose
Above this, IV is the better route
Cycle
Continuous
Many do 4 wks on / 1 wk off
mL
Defaults to 100 mg/mL on the small vial and 200 mg/mL on the larger ones — NAD+ doses are big enough that lower concentrations push past one syringe. Adjust to taste.
mg
Subcutaneous injection. Slow injection rate matters — over 30–60 seconds, not a quick push. Daily during ramp-up, often less frequent at maintenance.
Concentration
200.0 mg/mL
Per dose
0.25 mL
25 units on insulin syringe
Doses per vial
~10
~10 days (~1.4 weeks) of daily dosing

Ramp-up and maintenance — the most important section on this page

Phase 1: Ramp-up (weeks 1–4). NAD+ is the most dose-sensitive compound on this site. Going slow is non-negotiable; "I'll just start at the maintenance dose" is the most common way people end up with the chest pressure, anxiety, flushing, or GI symptoms that make NAD+ feel terrible. A typical ramp:

  • Week 1: 50 mg/day — assess baseline tolerance
  • Week 2: 100 mg/day if week 1 was clean
  • Week 3: 150 mg/day if still clean
  • Week 4: 200 mg/day — this is the working maintenance dose for most people

Phase 2: Maintenance (week 4 onward). Once you've ramped to a comfortable working dose, you have flexibility. Daily 100–200 mg works for many people. Others run the working dose 2–3 times per week instead, since NAD+ has a meaningful half-life and daily isn't strictly necessary once tissue levels are up. Some run 4 weeks on / 1 week off for a clearance window. None of these patterns is clearly superior — pick the one that fits your schedule and re-evaluate.

If side effects appear at any point: drop the dose by 50 mg, hold for a week at the lower dose, and re-attempt the higher dose only after symptoms have fully resolved. Don't push through. Side effects don't mean "it's working" — they mean the dose is moving faster than your body can handle. Slow injection rate (over 30–60 seconds rather than a quick push) also helps significantly.

Don't go above 250 mg per SubQ injection. Above this, volume becomes unwieldy, absorption gets less reliable, and the side-effect profile gets worse. If you need higher per-session doses, IV is the appropriate route — with appropriate clinical setup.

The honest read. Subjective reports of energy and clarity from NAD+ are real and consistent. Whether that effect is specifically NAD+ doing something durable for healthspan or aging, versus a near-term metabolic boost combined with placebo and routine, hasn't been rigorously disentangled. Don't extrapolate from "feels good" to "extends lifespan" — the human outcomes data isn't there.

For educational and research purposes only. This is not medical advice. NAD+ is not FDA-approved as a drug for any indication. Compounded forms operate outside FDA drug oversight. Long-term safety and outcomes data are limited. Consult a licensed healthcare provider before any health decision.

What people often ask

Will NAD+ make me feel younger?

Many people report feeling more energetic and clear-headed after IV NAD+. Whether that's specific to NAD+ or includes placebo, hydration, and the care-giving experience hasn't been disentangled. Oral NMN and NR have produced subtler effects in trials.

Is IV better than oral?

Honest answer: no rigorous head-to-head trials. IV delivers NAD+ directly to the bloodstream, which is faster but not necessarily more effective at the cellular level than oral precursors converted to NAD+ inside cells. The IV route has an experience element the supplements don't.

NMN vs NR, which is better?

Both raise NAD+ levels. NR has been on the market longer and has more human trial data. NMN had a rocky regulatory year recently when the FDA temporarily classified it as a "drug" rather than a supplement, then partially walked that back. From a biological standpoint, both end up as NAD+ in your cells.

How often do I need IV NAD+?

Longevity clinics typically suggest weekly to monthly infusions, sometimes with a "loading" series followed by maintenance. There's no rigorously validated frequency, so this is largely opinion-driven.

Is it safe?

Acute safety appears favorable across the available data. Long-term safety with chronic high-dose supplementation hasn't been comprehensively studied. Theoretical concerns about cancer biology exist (some cancer cells use NAD+ heavily) but haven't been clearly demonstrated as a clinical issue.

Will it extend my lifespan?

Mouse studies suggest some lifespan benefit. No human study has demonstrated that taking NMN, NR, or IV NAD+ extends human lifespan. That's a much harder thing to prove and the evidence isn't there.

What about post-COVID or chronic fatigue?

NAD+ has been used in some clinics for post-viral fatigue and long-COVID contexts. Anecdotal reports are positive. Rigorous trials in those populations are limited.

FDA and regulatory status

Status as of May 5, 2026: NAD+, NMN, and NR are not FDA-approved as drugs for any specific indication. Oral forms are regulated as dietary supplements (with the FDA's classification of NMN having changed multiple times in 2022–2024). IV NAD+ infusions are administered as compounded preparations at licensed clinics, outside FDA drug approval. Status updates land here when they happen.

Want to go deeper? Mechanism, sirtuin biology, IV vs oral pharmacokinetics, dosing, side effects, and references. Click to expand.

Background and biology

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell, essential for redox reactions in energy metabolism (glycolysis, the citric acid cycle, oxidative phosphorylation). It's also a substrate for several non-redox enzymes including sirtuins (SIRT1-7), PARPs, and CD38. The non-redox uses are the basis of the longevity hypothesis, sirtuins deacetylate proteins involved in aging-related processes, and they only function when NAD+ is available.

Tissue NAD+ levels decline with age, with steeper declines in some tissues (skin, brain, liver) than others. Multiple mechanisms contribute, including increased CD38-mediated NAD+ consumption with age and decreased synthesis.

Mechanism, sirtuins and beyond

Sirtuin pathway

Sirtuins are NAD+-dependent enzymes that deacetylate proteins involved in DNA repair, mitochondrial biogenesis, inflammation, and metabolic regulation. SIRT1 and SIRT3 in particular are central to the longevity hypothesis. When NAD+ is low, sirtuins can't function efficiently.

PARPs and DNA repair

Poly(ADP-ribose) polymerases consume NAD+ during DNA repair. Higher rates of DNA damage with age increase PARP activity, depleting NAD+, a feedback loop relevant to aging biology.

CD38 and NAD+ consumption

CD38, an enzyme expressed at higher levels with age and inflammation, consumes NAD+. Some longevity research targets CD38 inhibition as an alternative path to raising NAD+.

NMN and NR, different routes to NAD+

Oral NMN is converted to NAD+ via NMNAT enzymes inside cells. Oral NR is converted to NMN and then NAD+. Both reliably raise blood and tissue NAD+ levels in human trials. Bioavailability differs but the end metabolite is the same.

IV NAD+ pharmacokinetics

IV NAD+ raises plasma NAD+ levels rapidly, but cellular uptake is the bottleneck, extracellular NAD+ doesn't easily cross cell membranes. Some research suggests IV NAD+ is largely degraded to nicotinamide, which is then taken up by cells and re-synthesized into intracellular NAD+. So the cellular effect of IV NAD+ may not differ as much from oral precursors as the marketing implies.

Dosing across forms

These are not recommendations. Always consult a licensed healthcare provider before any clinical decision.

Oral NMN (typical research-community range): 250 to 1,000 mg per day.

Oral NR (typical): 250 to 1,000 mg per day. Sold under brand names like Niagen.

IV NAD+ (longevity-clinic protocols): 250 to 1,500 mg per infusion, slowly over 2 to 4+ hours. Loading series often involve daily infusions for 5 to 10 days, followed by weekly or monthly maintenance.

Long-term safety with high-dose chronic use has not been comprehensively studied for any of the three forms.

Side effects and safety profile

Reported with oral NMN and NR (typically mild and uncommon):

  • Mild flushing or warmth (uncommon)
  • Mild GI upset (uncommon)
  • Headache (rare)

Reported with IV NAD+ (some are unique to the IV route):

  • Flushing, chest tightness, "burning" sensation with fast-rate infusion (common with rapid administration; resolves with slower rates)
  • Headache during or after infusion
  • Nausea
  • Anxiety-like sensations during infusion

Slow infusion rates (over 2+ hours) substantially reduce the IV-specific symptoms. Theoretical considerations include potential effects on cancer biology (some cancer cells are NAD+-dependent), which haven't been clearly demonstrated as a clinical concern but warrant caution in active malignancy.

References

  1. Yoshino J, Baur JA, Imai SI. (2018). "NAD+ intermediates: the biology and therapeutic potential of NMN and NR." Cell Metab, 27(3), 513–528. PubMed
  2. Trammell SA, Schmidt MS, Weidemann BJ, et al. (2016). "Nicotinamide riboside is uniquely and orally bioavailable in mice and humans." Nat Commun, 7, 12948. PubMed
  3. Mills KF, Yoshida S, Stein LR, et al. (2016). "Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice." Cell Metab, 24(6), 795–806. PubMed
  4. Yoshino M, Yoshino J, Kayser BD, et al. (2021). "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science, 372(6547), 1224–1229. PubMed
  5. Grant R, Berg J, Mestayer R, et al. (2019). "A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+." Front Aging Neurosci, 11, 257. PubMed
  6. Sinclair DA, Guarente L. (2014). "Small-molecule allosteric activators of sirtuins." Annu Rev Pharmacol Toxicol, 54, 363–380. PubMed
For educational and research purposes only. This is not medical advice. NAD+, NMN, and NR are not FDA-approved as drugs for any specific indication. Consult a licensed healthcare provider before considering any IV-NAD+ protocol. PeptideLibraryHub is independent and does not sell peptides or accept money from anyone who does.